Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

Author(s): Miyamoto M, Ojima h, Iwasaki M, Shimizu H, Kokubu A, et al.

Abstract

Background:

Cholangiocarcinoma (CC) is a highly malignant carcinoma. We attempted to clarify the prognostic significance of c-Met overexpression and its association with clinicopathological factors in patients with CC.

Patients and methods:

One hundred and eleven patients with intrahepatic CC (IHCC) and 136 patients with extrahepatic CC (EHCC) who had undergone curative surgery were divided immunohistologically into c-Methigh and c-Metlow groups. Clinicopathological factors and outcomes were compared between the groups. c-Met and epidermal growth factor receptor (EGFR) expression was also examined in 10 CC cell lines.

Results:

The positivity of c-Met was 45.0% in IHCC and 68.4% in EHCC; c-Methigh expression was demonstrated in 11.7% of IHCC and 16.2% of EHCC. c-Methigh expression was significantly correlated with the 5-year survival rate for CC overall (P=0.0046) and for IHCC (P=0.0013), histopathological classification in EHCC, and for EGFR overexpression in both IHCC and EHCC. Coexpression and coactivation of c-Met and EGFR were also observed in CC cell lines. Multivariate analysis revealed that c-Methigh expression was an independent predictor of poor overall and disease-free survival in patients with IHCC.

Conclusions:

c-Met overexpression is associated with EGFR expression and is a poor prognostic factor in CC.

Similar Articles

Clinicopathological significance of fatty acid synthase expression in carcinoma of the Ampulla of Vater

Author(s): Maekawa H, Ito T, Kushida T, Orita H, Sakurada M, et al.

Cancer Review: Cholangiocarcinoma

Author(s): Ghouri YA, Mian I, Blechacz B

Epidemiology of cholangiocarcinoma

Author(s): Bergguist A, von Seth E

Prognostic impact of lymph node metastasis in distal cholangiocarcinoma

Author(s): Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, et al.

Prognositc factors for survival after curative resection of distal cholangiocarcinoma

Author(s): Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, et al.

Prognostic factors in patients with middle and distal bile duct cancers

Author(s): Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ

Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand

Author(s): Pattanathien P, Khuntikeo N, Promthet S, Kamsa-Ard S

Distal cholangiocarcinoma

Author(s): Lad N, Kooby DA